Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1237-1254
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1237
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1237
Figure 2 HOXD-AS2 is downregulated in gastric cancer cells.
A: The expression of HOXD-AS2 was downregulated in gastric cancer AGS, MGC-803, SGC-7901, BGC-823, and SNU-1 cells compared with gastric epithelial GES-1 cells; B: The expression of HOXD-AS2 in SGC-7901 and SNU-1 cells after transfections. The results are shown as the mean ± SD. bP < 0.01, eP < 0.001.
- Citation: Yao L, Ye PC, Tan W, Luo YJ, Xiang WP, Liu ZL, Fu ZM, Lu F, Tang LH, Xiao JW. Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway. World J Gastrointest Oncol 2020; 12(11): 1237-1254
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1237.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1237